top of page
Browse by category
Search
OAC and TOS urge FDA to enforce GLP-1s compounding regulations
The Obesity Action Coalition (OAC) and The Obesity Society (TOS) have sent a letter to the FDA, along with more than 20 leading...
The Obesity Society commends FDA's resolution of obesity drug shortages and calls for enforcement against unauthorised compounding
The Obesity Society (TOS) has acknowledged the FDA’s recent announcement declaring the end of shortages for Novo Nordisk's Wegovy and...
Workshop identifies challenges and opportunities to improve care for patients with obesity and CKD
A step toward improved collaboration between the nephrology and obesity medicine communities in managing persons with concurrent obesity...
Greater diversity needed in membership and representatives of obesity organisations
Obesity and nutrition-focused professional organisations need to increase the diversity of membership and leadership at the presidential...
Browse by tag
bottom of page